AlphaVax
Blood & Organ Banks · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2 Triangle Dr, Durham, North Carolina, 2...Phone Number
(919) 595-0400Website
www.alphavax.comRevenue
$14 MillionIndustry
About AlphaVax
AlphaVax Inc. is a clinical-stage biopharmaceutical company specializing in vaccine development using proprietary RNA particle technology for both human and veterinary applications. The company focuses on creating anti-infective and anti-cancer vaccines, with a particular emphasis on cancer immunotherapy. AlphaVax has developed a portfolio of seven vaccine candidates, including those targeting human cytomegalovirus, influenza A virus, prostate cancer, and HIV-1, and has conducted multiple Phase 1 clinical trials. Their innovative approach aims to engage the immune system to recognize and combat various cancers, demonstrating promising results in enhancing patient survival.Explore more
AlphaVax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to AlphaVax
Compare insights from companies similar to AlphaVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AlphaVax
$14M
51-200
Private
$31.9M
1997
AG
Andrew GrahamTechnical Operations Vice President, Development
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
AlphaVax Tech Stack
A closer look at the technologies used by AlphaVax
See more technologies
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AlphaVax
Sign Up For FreeTo access detailed company insights
AlphaVax Inc. is a clinical-stage biopharmaceutical company specializing in vaccine development using proprietary RNA particle technology for both human and veterinary applications. The company focuses on creating anti-infective and anti-cancer vaccines, with a particular emphasis on cancer immunotherapy. AlphaVax has developed a portfolio of seven... Read More
